Skip to main content
Abpro Holdings, Inc. logo

Abpro Holdings, Inc. — Investor Relations & Filings

Ticker · ABP ISIN · US04845A1088 US Professional, scientific and technical activities
Open in API
Filings indexed 243 across all filing types
Latest filing 2026-06-04 Delisting Announcement
Country US United States of America
Listing US ABP

About Abpro Holdings, Inc.

https://abpro.co/

Abpro Holdings, Inc. is a clinical-stage biotechnology company that develops next-generation antibody therapeutics. The company focuses on creating novel antibody constructs for challenging and high-value targets in immuno-oncology and ophthalmology. Its pipeline includes therapies targeting various cancers such as HER2-positive (HER2+) breast and gastric cancers, as well as non-HER2+ gastric, colorectal, and liver cancers. In ophthalmology, Abpro is developing treatments for conditions like wet age-related macular degeneration. The company utilizes its proprietary DiversImmune™ platform to engineer and discover its therapeutic candidates, aiming to address severe and life-threatening diseases with significant unmet medical needs.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Delisting Announcement Classification · 98% confidence The document is a Form 8-K Current Report by Abpro Holdings, Inc. dated May 28, 2026, containing Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. It describes Nasdaq’s decision to delist the company’s securities and the expected suspension of trading, which clearly falls under a Delisting Announcement.
2026-06-04 English
QUARTERLY REPORT
Interim / Quarterly Report Q1 2026
2026-05-20 English
10-K - Abpro Holdings, Inc. (0001893219) (Filer)
Annual Report FY 2025
2026-04-15 English
8-K - ABPRO HOLDINGS, INC. (0001893219) (Filer)
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The key content is an Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. It details that the company, Abpro Holdings, Inc., received notification from Nasdaq that its securities will be delisted due to non-compliance with listing standards. The document discusses the delisting process, potential appeal, and trading suspension date. This is a formal delisting announcement, not a full financial report or earnings release. The document length is 7,536 characters, which is sufficient for a detailed announcement but does not contain financial statements or management discussion. Therefore, the appropriate classification is Delisting Announcement (DLST).
2026-02-20 English
8-K Filing
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content specifically details the resignation of two board members, the resulting non-compliance with Nasdaq listing rules, notices from Nasdaq regarding delisting risks, and the appointment of new directors to the board and committees. There is no financial data or earnings information, nor is this an annual or quarterly report. The primary focus is on changes in the company's board of directors and compliance with listing requirements. Therefore, this document fits the category of Board/Management Information (MANG). The document length is over 10,000 characters, indicating it is a full report rather than a brief announcement. Hence, the classification is MANG with high confidence.
2026-02-11 English
8-K Filing
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated January 28, 2026, by Abpro Holdings, Inc. The key content is under Item 5.02, which reports the resignation of two directors from the Board and the company's plan to appoint new independent directors. This is a clear announcement of changes in the company's board of directors. There is no financial data or report attached, nor is this a report publication announcement. The document fits the category of Board/Management Information (MANG) as it concerns changes in the board of directors.
2026-02-03 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.